Abstract |
The purpose of this investigation was to conduct a prospective trial to assess the effectiveness of a 4% sclerosing alcohol injection in a small group of patients with intermetatarsal neuromas who had failed previous conservative therapies including corticosteroid injections. Six patients with 8 neuromas were followed for a mean 346 days. A weekly series of 3-9 injections containing 1 mL of the 4% alcohol sclerosing solution were given based on patient response to treatment. Pre- and posttreatment surveys consisting of both objective and subjective findings including a visual analog pain scale were collected. The average pretreatment visual analog pain rating was 7.5 +/- 1.14. The average posttreatment visual analog pain rating was 1.38 +/- 2.39 with an average reduction of 6.13. The average reported improvement in symptoms was 73%. Five of the 6 patients would recommend the treatment to a friend or family member. No complications were encountered. Two neuromas in 2 patients failed the sclerosing injection course: 1 ultimately responded to antiinflammatory use and the other underwent excision.
|
Authors | Christopher F Hyer, Lynette R Mehl, Alan J Block, Robert B Vancourt |
Journal | The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
(J Foot Ankle Surg)
2005 Jul-Aug
Vol. 44
Issue 4
Pg. 287-91
ISSN: 1067-2516 [Print] United States |
PMID | 16012436
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Sclerosing Solutions
- Ethanol
|
Topics |
- Aged
- Aged, 80 and over
- Ethanol
(administration & dosage, therapeutic use)
- Female
- Foot Diseases
(therapy)
- Humans
- Injections
- Male
- Middle Aged
- Neuroma
(therapy)
- Pilot Projects
- Prospective Studies
- Sclerosing Solutions
(administration & dosage, therapeutic use)
- Treatment Outcome
|